These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 33255393)
1. Long-Term Clinical Outcome of Cardiogenic Shock Patients Undergoing Impella CP Treatment vs. Standard of Care. Scherer C; Lüsebrink E; Kupka D; Stocker TJ; Stark K; Stremmel C; Orban M; Petzold T; Germayer A; Mauthe K; Kääb S; Mehilli J; Braun D; Theiss H; Brunner S; Hausleiter J; Massberg S; Orban M J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33255393 [TBL] [Abstract][Full Text] [Related]
2. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience. Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366 [TBL] [Abstract][Full Text] [Related]
3. Impella CP use in patients with non-ischaemic cardiogenic shock. Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Impella CP insertion during cardiac arrest: A single center experience. Kamran H; Batra S; Venesy DM; Patten RD; Waxman S; Pyne C; Shah SP Resuscitation; 2020 Feb; 147():53-56. PubMed ID: 31891791 [TBL] [Abstract][Full Text] [Related]
5. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock. Haertel F; Lenk K; Fritzenwanger M; Pfeifer R; Franz M; Memisevic N; Otto S; Lauer B; Weingärtner O; Kretzschmar D; Dannberg G; Westphal J; Baez L; Bogoviku J; Schulze PC; Moebius-Winkler S J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956238 [TBL] [Abstract][Full Text] [Related]
6. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière. Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912 [TBL] [Abstract][Full Text] [Related]
7. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock. Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591 [TBL] [Abstract][Full Text] [Related]
8. The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest. Vase H; Christensen S; Christiansen A; Therkelsen CJ; Christiansen EH; Eiskjær H; Poulsen SH Resuscitation; 2017 Mar; 112():70-74. PubMed ID: 27751862 [TBL] [Abstract][Full Text] [Related]
9. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock. Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290 [TBL] [Abstract][Full Text] [Related]
10. Outcome of the impella device for acute mechanical circulatory support. Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552 [TBL] [Abstract][Full Text] [Related]
12. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Mechanical Support with Impella or Extracorporeal Life Support in Post-Cardiac Arrest Cardiogenic Shock: A Propensity Scoring Matching Analysis. Syntila S; Chatzis G; Markus B; Ahrens H; Waechter C; Luesebrink U; Divchev D; Schuett H; Tsalouchidou PE; Jerrentrup A; Parahuleva M; Schieffer B; Karatolios K J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441879 [TBL] [Abstract][Full Text] [Related]
14. Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle. Josiassen J; Helgestad OKL; Udesen NLJ; Banke A; Frederiksen PH; Hyldebrandt JA; Schmidt H; Jensen LO; Hassager C; Ravn HB; Møller JE Intensive Care Med Exp; 2020 Aug; 8(1):41. PubMed ID: 32785808 [TBL] [Abstract][Full Text] [Related]
15. The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock. Pieri M; Sorrentino T; Oppizzi M; Melisurgo G; Lembo R; Colombo A; Zangrillo A; Pappalardo F J Interv Cardiol; 2018 Dec; 31(6):717-724. PubMed ID: 30460719 [TBL] [Abstract][Full Text] [Related]
16. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock. Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321 [TBL] [Abstract][Full Text] [Related]
17. Microaxial flow pump (Impella CP®) in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Beske RP; Terkelsen CJ; Schäfer A; Møller JE; Hassager C Kardiol Pol; 2024; 82(7-8):702-707. PubMed ID: 39140671 [TBL] [Abstract][Full Text] [Related]
18. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients. Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095 [No Abstract] [Full Text] [Related]
19. Outcomes of Renal Function in Cardiogenic Shock Patients With or Without Mechanical Circulatory Support. Upadhyaya VD; Alshami A; Patel I; Douedi S; Quinlan A; Thomas T; Prentice J; Calderon D; Asif A; Sen S; Mehra A; Hossain MA J Clin Med Res; 2021 May; 13(5):283-292. PubMed ID: 34104280 [TBL] [Abstract][Full Text] [Related]
20. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]